News

According to the company, the system was introduced into the Japanese industrial market with a high acceptance due to the improved productivity of their processes and significant savings

In relation to the acquisition of Ranbaxy shares announced in June 2008, and in accordance with the legal requirements in India, Daiichi Sankyo is scheduled to implement an

Edunn’s lead drug candidate, EDN-OL1, is an oligonucleotide-based drug that has shown promise in halting and reversing the progression of Alzheimer’s disease (AD) in animal models. EDN-OLI reduces

In a recent study, ConsumerLab.com evaluated coenzyme Q10 (CoQ10) and ubiquinol products from various nutritional supplement manufacturers to determine whether they contained the amounts of the compounds as

Levetiracetam oral solution, 100 mg/ml is the AB-rated bioequivalent generic to UCB Pharma’s Keppra, 100mg/ml. Cypress’s levetiracetam oral solution, 100mg/ml will be available through all the national drug

Under the agreement, members of Blue Shield of California’s managed care plans will retain access to Tenet’s 13 acute-care hospitals and three freestanding ambulatory surgery centers for their

Mr Fitch is the president and CEO of The Westaim Corporation, Nucryst’s controlling shareholder, holding approximately 75% of Nucryst’s outstanding common shares. Prior to his appointment as president

Pfizer is reviewing the letter and will work with the FDA to determine the appropriate next steps regarding the company’s application. Pfizer has submitted the current application for

Advanced Medical Optics’s (AMO) Tecnis multifocal intraocular lens (IOL) are indicated for primary implantation for the visual correction of aphakia in adult patients with and without presbyopia in